SCHEMBL3376310

SCHEMBL3376310

CCOC(=O)Cn1c(C)cc2c1CC(C)(C)CC2=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
KDM4E B2RXH2 4/20 0.49
HSD17B10 Q99714 2/20 0.49
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
RAB9A P51151 1/20 0.44
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.41
TP53 P04637 2/20 0.40
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
CASP1 P29466 1/20 0.39
PIN1 Q13526 1/20 0.39
PIN4 Q9Y237 1/20 0.39
OPRM1 P35372 1/20 0.39
THRB P10828 1/20 0.38
BUB1 O43683 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15292435 0.84 ALDH1A1 (0.48) ALDH1A1KDM4EHSD17B10KMT2AMEN1
SCHEMBL13492263 0.81 HTT (0.56) ALDH1A1KDM4EHSD17B10KMT2AMEN1
SCHEMBL16507769 0.80 RAB9A (0.43) ALDH1A1KDM4EKMT2AMEN1RAB9A
SCHEMBL1055360 0.79 LMNA (0.51) ALDH1A1KDM4EHSD17B10KMT2AMEN1
SCHEMBL3370616 0.77 RAB9A (0.41) ALDH1A1KDM4EHSD17B10KMT2AMEN1
SCHEMBL370114 0.74 RAB9A (0.41) ALDH1A1KDM4EHSD17B10KMT2AMEN1
SCHEMBL14903171 0.72 KMT2A (0.43) ALDH1A1KDM4EHSD17B10KMT2AMEN1
SCHEMBL14903177 0.72 KMT2A (0.43) ALDH1A1KDM4EHSD17B10KMT2AMEN1
SCHEMBL16495409 0.72 PKN2 (0.44) ALDH1A1KDM4EHSD17B10KMT2AMEN1
SCHEMBL13417390 0.71 HTT (0.41) ALDH1A1KDM4EHSD17B10HTTGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130259830-A1 CRTH2 MODULATORS IRONWOOD PHARMACEUTICALS, INC. (US) 2013-10-03 US disclosed
US-20130259830-A1 CRTH2 MODULATORS IRONWOOD PHARMACEUTICALS, INC. (US) 2013-10-03 US disclosed
US-20130259830-A1 CRTH2 MODULATORS IRONWOOD PHARMACEUTICALS, INC. (US) 2013-10-03 US disclosed
WO-2012009134-A1 CRTH2 MODULATORS IRONWOOD PHARMACEUTICALS, INC. (US) 2012-01-19 WO disclosed
US-20110312945-A1 CRTH2 MODULATORS IRONWOOD PHARMACEUTICALS, INC. 2011-12-22 US disclosed
US-20110312945-A1 CRTH2 MODULATORS IRONWOOD PHARMACEUTICALS, INC. 2011-12-22 US disclosed
US-20110312945-A1 CRTH2 MODULATORS IRONWOOD PHARMACEUTICALS, INC. 2011-12-22 US disclosed
WO-2010039982-A1 CRTH2 MODULATORS IRONWOOD PHARMACEUTICALS, INC. (US) 2010-04-08 WO disclosed
WO-2010039982-A1 CRTH2 MODULATORS IRONWOOD PHARMACEUTICALS, INC. (US) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312945-A1 CRTH2 MODULATORS HRH2, HRH1, NR1H2 ALDH1A1 851/4885KDM4E 4506/4885HSD17B10 854/4885
US-20130259830-A1 CRTH2 MODULATORS HRH2, HRH1, NR1H2 ALDH1A1 832/4885KDM4E 4499/4885HSD17B10 833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.